Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Urology|September 8, 2004
Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology GroupHelena Linardou, Gerassimos Aravantinos, Eleni Efstathiou, et al.
The Oncologist|April 10, 2020
Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated MelanomaDimitrios C Ziogas, Panagiotis Diamantopoulos, Olga Benopoulou, et al.
Cancer Treatment Reviews|September 7, 2010
All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancerHelena Linardou, Evangelos Briasoulis, Issa J Dahabreh, et al.
Anticancer Research|June 25, 2003
Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility studyHaralabos P Kalofonos, Dimitrios Kardamakis, Aristotelis Bamias, et al.
Gynecologic Oncology|July 23, 2008
Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) studyChristos A Papadimitriou, George Fountzilas, Dimitrios Bafaloukos, et al.
Breast Cancer Research and Treatment|December 3, 2005
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenGeorge Pentheroudakis, George Fountzilas, Dimitrios Bafaloukos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2019
The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumabErofili Papadopoulou, Ourania Nicolatou-Galitis, Ioannis Papassotiriou, et al.
Melanoma Research|January 3, 2019
Prognostic significance of distant metastasis-free interval in patients with relapsed melanoma treated with BRAF with or without MEK inhibitorsDimitrios Bafaloukos, George Papaxoinis, Helena Linardou, et al.
Gynecologic Oncology|June 8, 2002
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology GroupMeletios A Dimopoulos, Christos A Papadimitriou, Kyrillos Sarris, et al.
American Journal of Clinical Oncology|December 13, 2002
Lymphocyte subpopulations and interleukin levels in high-risk melanoma patients treated with high-dose interferon A-2BHelen Gogas, George Paterakis, Konstantina Frangia, et al.
Pageof 11